The stock price of AIM ImmunoTech Inc (AMEX: AIM) has surged by 8.87 when compared to previous closing price of 0.49, but the company has seen a 12.94% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2024-04-02 that AIM ImmunoTech Inc. (NYSE:AIM ) Q4 2023 Earnings Conference Call April 2, 2024 8:30 AM ET Company Participants Thomas Equels – Chief Executive Officer Dr. Christopher McAleer – Scientific Officer Conference Call Participants James Molloy – Alliance Global Partners Ed Woo – Ascendiant Capital Markets Operator Hello. And welcome to the AIM ImmunoTech Fiscal Year 2023 Update Conference Call and Webcast.
Is It Worth Investing in AIM ImmunoTech Inc (AMEX: AIM) Right Now?
The stock has a 36-month beta value of -0.15. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AIM is 45.32M, and at present, short sellers hold a 1.09% of that float. On April 10, 2024, the average trading volume of AIM was 194.98K shares.
AIM’s Market Performance
AIM stock saw an increase of 12.94% in the past week, with a monthly gain of 49.39% and a quarterly increase of 17.99%. The volatility ratio for the week is 9.51%, and the volatility levels for the last 30 days are 11.35% for AIM ImmunoTech Inc (AIM). The simple moving average for the last 20 days is 25.11% for AIM stock, with a simple moving average of 7.09% for the last 200 days.
AIM Trading at 29.22% from the 50-Day Moving Average
After a stumble in the market that brought AIM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.17% of loss for the given period.
Volatility was left at 11.35%, however, over the last 30 days, the volatility rate increased by 9.51%, as shares surge +50.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +26.90% upper at present.
During the last 5 trading sessions, AIM rose by +11.95%, which changed the moving average for the period of 200-days by +13.91% in comparison to the 20-day moving average, which settled at $0.4388. In addition, AIM ImmunoTech Inc saw 22.26% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AIM starting from BRYAN NANCY, who purchase 38,462 shares at the price of $0.39 back on Mar 21 ’24. After this action, BRYAN NANCY now owns 38,462 shares of AIM ImmunoTech Inc, valued at $15,000 using the latest closing price.
APPELROUTH STEWART, the Director of AIM ImmunoTech Inc, purchase 90,910 shares at $0.33 during a trade that took place back on Mar 15 ’24, which means that APPELROUTH STEWART is holding 239,765 shares at $30,000 based on the most recent closing price.
Stock Fundamentals for AIM
Current profitability levels for the company are sitting at:
- -156.25 for the present operating margin
- -0.36 for the gross margin
The net margin for AIM ImmunoTech Inc stands at -139.35. The total capital return value is set at -2.93. Equity return is now at value -118.94, with -64.84 for asset returns.
Based on AIM ImmunoTech Inc (AIM), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -95.37. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 49.78.
Currently, EBITDA for the company is -31.66 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 114.15. The receivables turnover for the company is 0.17for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.68.
Conclusion
To sum up, AIM ImmunoTech Inc (AIM) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
